133 related articles for article (PubMed ID: 23222303)
1. Neuropilin-1 identifies a subset of bone marrow Gr1- monocytes that can induce tumor vessel normalization and inhibit tumor growth.
Carrer A; Moimas S; Zacchigna S; Pattarini L; Zentilin L; Ruozi G; Mano M; Sinigaglia M; Maione F; Serini G; Giraudo E; Bussolino F; Giacca M
Cancer Res; 2012 Dec; 72(24):6371-81. PubMed ID: 23222303
[TBL] [Abstract][Full Text] [Related]
2. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity.
Casazza A; Laoui D; Wenes M; Rizzolio S; Bassani N; Mambretti M; Deschoemaeker S; Van Ginderachter JA; Tamagnone L; Mazzone M
Cancer Cell; 2013 Dec; 24(6):695-709. PubMed ID: 24332039
[TBL] [Abstract][Full Text] [Related]
3. VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells.
Fons P; Herault JP; Delesque N; Tuyaret J; Bono F; Herbert JM
J Cell Physiol; 2004 Sep; 200(3):351-9. PubMed ID: 15254962
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice.
Davidoff AM; Ng CY; Brown P; Leary MA; Spurbeck WW; Zhou J; Horwitz E; Vanin EF; Nienhuis AW
Clin Cancer Res; 2001 Sep; 7(9):2870-9. PubMed ID: 11555605
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
[TBL] [Abstract][Full Text] [Related]
6. Chapter 15. Methods to study myeloid cell roles in angiogenesis.
Schmid MC; Varner JA
Methods Enzymol; 2008; 445():343-71. PubMed ID: 19022067
[TBL] [Abstract][Full Text] [Related]
7. The influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16(F10) murine melanoma cells.
Mazurek AM; Olbryt M
Neoplasma; 2012; 59(1):43-51. PubMed ID: 22082309
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.
Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V
Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992
[TBL] [Abstract][Full Text] [Related]
9. Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells.
Udagawa T; Puder M; Wood M; Schaefer BC; D'Amato RJ
FASEB J; 2006 Jan; 20(1):95-102. PubMed ID: 16394272
[TBL] [Abstract][Full Text] [Related]
10. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression.
Miao HQ; Lee P; Lin H; Soker S; Klagsbrun M
FASEB J; 2000 Dec; 14(15):2532-9. PubMed ID: 11099472
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of neuropilin-1 and its receptors, VEGF/Semaphorin 3a, in normal and cancer cells.
Haixia D; Jingsong Z; Lei J; Hairong D; Jun W; Hang X; Weixian C
Cell Biochem Biophys; 2011 Jan; 59(1):39-47. PubMed ID: 20711684
[TBL] [Abstract][Full Text] [Related]
12. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
[TBL] [Abstract][Full Text] [Related]
13. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
Kawakami T; Tokunaga T; Hatanaka H; Kijima H; Yamazaki H; Abe Y; Osamura Y; Inoue H; Ueyama Y; Nakamura M
Cancer; 2002 Nov; 95(10):2196-201. PubMed ID: 12412174
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
15. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth.
Ogawa Y; Suzuki T; Oikawa A; Hosono K; Kubo H; Amano H; Ito Y; Kitasato H; Hayashi I; Kato T; Sugimoto Y; Narumiya S; Watanabe M; Majima M
Biochem Biophys Res Commun; 2009 May; 382(4):720-5. PubMed ID: 19318087
[TBL] [Abstract][Full Text] [Related]
17. Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models.
Casazza A; Fu X; Johansson I; Capparuccia L; Andersson F; Giustacchini A; Squadrito ML; Venneri MA; Mazzone M; Larsson E; Carmeliet P; De Palma M; Naldini L; Tamagnone L; Rolny C
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):741-9. PubMed ID: 21205984
[TBL] [Abstract][Full Text] [Related]
18. VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy.
Greenberg JI; Cheresh DA
Expert Opin Biol Ther; 2009 Nov; 9(11):1347-56. PubMed ID: 19761418
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
[TBL] [Abstract][Full Text] [Related]
20. Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.
Shojaei F; Wu X; Malik AK; Zhong C; Baldwin ME; Schanz S; Fuh G; Gerber HP; Ferrara N
Nat Biotechnol; 2007 Aug; 25(8):911-20. PubMed ID: 17664940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
